Pyrr, aka, steve is no longer the Pyrr or steve you know. His soul is now bought by (?) no different than anyone else who sell his soul.
You came out with a conclusion based on only one side of him (his recent commentaries) but you need to make your conclusion based on all his commentaries/history. He is no more than a bipolar if you combine all his commentaries with correlation with his sell and buy 'recommendation" history. That's it, a bipolar!
It's nothing wrong to have his view changed or not, changed how often or changed for his own personal purpose, but it is wrong to pretend he is no so, evidenced by you one of his victim, if you have heeded his call and buy some put!
As far as the stock price is concerned, you and he are now just spreading FUDs, nothing more or less!
JFYI: nobody, even cramer would have had any impact on stock prices, particularly those of small caps, if he has not been willing to serve as "unofficial representative" or "front" for some funds, long or shorts behind the scene each time and every time the stock price is manipulated. [Pyrr may have to work hard for next 100 years before he has any chance to be one Cramer or even AF]
Pyrr is nobody, me nobody either. You know that and we all know that and he knows that even more so, although he may think otherwise after a few drinks. Anyone can write SA articles. The movement of the underlying share price is not impacted by how many SA articles and/or the qualities of the articles one may write, but related to whether there are any funds behind it. [Only Pyrr knows does he get money from any fund?]
Now please leave him in his IHUB village, never ever bring him to this board. Of course, you have the right of freedom of speech.
Our yahooers' price target is $30 before either of L and D results are known; $60 ~ $100 for the success of first indication of L; and $1,000 for both L and D.
I am pumping and I am dreaming. God, may my dream come true! May patients have more choices!
Since Antimachine-kudo and later I posted daily information about shortable shares availability according to Interactive Broker, the truth is that almost every and each day, that number has been almost zero and in a few occasions, the number has been just a mere thousand, hundred, or even jokingly a dozen for quite some time now.
It suggests on the one hand, shorts cannot find any shares to continually short and thus continually manipulate the stock price down as was the case in the past, which is evidenced by the huge existing shorted share counts (about 10 millions plus maybe 4 millions naked shorts according to SmithonStock); on the other hand, Neil Woodford and some other funds, and more and more retail investors have bought and increased their shares to significantly reduce the float (which has scared the shorts, evidenced by their desperations and innovations in FUDs).
Conclusion: From a pure technical perspective, the only way shorts now can do to bring down the share price is to ask people to buy put contracts, in the disguise as hedging or not.
For the sake of patients, may God help us longs, thus help them in the form of a costly lesson!
Yes, the idiot in IHub has made the number of pseudo progression patients at 24 as if it is a fact. Now we know only one patient is confirmed to be pseudo pression. Yes, as you said for most conservative point of view (impossible) by assuming all those 25 indeterminate patients are pseudo, the results are sill unbelievable positive and unheard of.
Vol. 4, No. 2, Pages 63-69 , DOI 10.2217/cns.14.54
Dendritic cell immunotherapy for solid tumors: evaluation of the DCVax® platform in the treatment of glioblastoma multiforme
Alia Hdeib1 & Andrew Edward Sloan*,1,2,3
*Author for correspondence: Andrew.Sloan@UHhospitals.org
DCVax® (Northwest Biotherapeutics, Inc., MD, USA) is a platform technology for delivering dendritic cell based therapeutic vaccines for a variety of cancers, including glioblastoma multiforme (GBM). DCVax®-L, one of the implementations of the DCVax platform, provides personalized active immunotherapy composed of autologous dendritic cells pulsed with autologous whole tumor lysate. Clinical trials with DCVax-L for GBM included previous Phase I/II clinical trials and an ongoing Phase III trial. Preliminary reports of patient outcomes after administration of the DCVax-L vaccine provide a promising therapeutic paradigm for patients with both initially diagnosed and recurrent GBM. Here we evaluate the current literature and clinical experience with the DCVax platform, with a particular focus on GBM treatment.
DCVax we believe! When its day comes with great treatments for patients with both operable and inoperable cancers of various types and forms, today's big pharms will be tomorrow's small pharms compared to Northwest Biotherapeutics!
Completely agreed. the huge April call volumes must mean something one way or the other!
That's why hedge funds are no popular thing any more for these guys have recklessly played customers money for so long and nobody has trust them anymore!
A perfect example is vvus.
First, they shorted, shorted and shorted. Now there are no shortable shares available for them to short;
Then, they have spread fuds in message boards to gently and friendly ask anyone of nwbo shareholder to hedge via buying put options (with the same effect of driving down the price as does with shorting);
Now, they are calling their buddy Cramer as AF has been warned by SEC, and Justice Department (so he has to be careful) to seed and spread fuds with his intentionally low-quality and apparent ignorant analysis in effort to scare or entice some retail longs to sell (to luck profit) so his short buddies can readily pick them up.
Wow, how desperate shorts have been recently? Could it be true that the real storm is coming with some definite short bury news?
Please keep it up if you agree. Thank you.
The results for the most difficult to treat groups have shown the future of DCVax-L.
Thumb up for your sentiment. but "Pyrr is undoubtedly intelligent and influential, " First word is true. Influential? you must be joking.
He may have a few fans (or maybe several dozens of readers gained after he wrote a couple of jargons laden, statistics ABC showy SA articles) to follow him. That's it. After this recent episode of bipolar diagnosis, he may have lost them all.
Market is not moved by his comments. He sold at around $7 in the recent price appreciation all the way up to about $8.6, and he since turn negative. Actually, based on what he has said recently, he may just be a new short.
I hate to mention his name (this is the first and last time). It makes me sick!
It is delicious!
And I have also promise to send my recipe to Cramer about Cramer toast and AF Peanut Butter when we celebrate the success of either L and D, which is coming soon.
And surprisingly, he refused. So I made it open here. LOL.
first of all, senti. You have my respect judged by your consistence here and over there, and you seem to be one of a few of those people I respect in IHub, including RK, Meveric, Dan88, flipper, etc.
Nonetheless, your sense is sometimes well off: The most recent case is your overreaction on D-data embargo, which I deemed it a fud. Secondly, you said the same thing about pyrr a short time ago the way you did on rrr.
My deep and sincere sympathy to rrr on his unimaginable loss. But he is after all an investor, no different from any of us.
I don't have problem that people are long or short on any stock. My problem with some people are they are very deep down disingenuous, and manipulative (not for rrr, but referred to Pyrr).
My pray for those who suffer!
The big pharms are scared for the potential huge successes of DCVax platform, which will make a big chunk of their business useless, so it comes Cramer, the big pharm boy, and so it comes AF, the little warrior against small pharms.
So it comes dozens of contractors, making a dime or a buck commission per post for selling their souls to the corrupted part of America.
But, NWBO has at this stage well developed enough to weather any storms, and has not put itself for sale.
We are talking about billions or even 200 billion potential market cap for NWBO.
BTW, we have presentations on 26 March in Germany, on 9 April in Washington DC before 20 April in Philadelphia.
In between there may be some material news!
Exactly! Ignore any fud. See recently, how desperate the shorts have become!
I believe both L and D will excell in late this year (L, stopped out for efficacy), and next year for D. If that is the case, a market cap of 200 billion may not be a long short.
This indeed has scared shorts. They are calling anyone and anything that can help them. Cramer may be the last straw for the shorts to see their end for one more day! Scare the retails and scoop the shares! What a wonderful wishful thinking!
Can someone phone him and let him know his short friends are so luck today that they can borrow a huge 2k shares to short?
courtesy of Interactive Brokers